April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
A POAG-Associated STI1 Variant is Functionally Deficient and Genetically Interacts With UTP21/WDR36
Author Affiliations & Notes
  • M. A. Walter
    Medical Genetics, University of Alberta, Edmonton, Alberta, Canada
  • T. Footz
    Medical Genetics, University of Alberta, Edmonton, Alberta, Canada
  • S. Dubois
    Ocular Genetics & Genomics, CHUL Research Center, Quebec City, Quebec, Canada
  • V. Raymond
    Ocular Genetics & Genomics, CHUL Research Center, Quebec City, Quebec, Canada
  • Footnotes
    Commercial Relationships  M.A. Walter, None; T. Footz, None; S. Dubois, None; V. Raymond, None.
  • Footnotes
    Support  This work was supported by the Canadian Institutes of Health Research (MOP77782 to M.A.W and V.R.); The Glaucoma Foundation (G700000350 to M.A.W.)
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 2146. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M. A. Walter, T. Footz, S. Dubois, V. Raymond; A POAG-Associated STI1 Variant is Functionally Deficient and Genetically Interacts With UTP21/WDR36. Invest. Ophthalmol. Vis. Sci. 2010;51(13):2146.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Glaucoma is a common neurodegenerative disease characterized by progressive irreversible blindness and frequently presents with increased intra-ocular pressure. A variety of loci have been linked to inherited forms of the most common subtype, primary open-angle glaucoma (POAG), including one on 5q22.1 that harbors the rRNA-processing gene WDR36. The occurrence of rare non-synonymous WDR36 sequence variants in normal control subjects supports the theory that the genetics of POAG is complex, where the normally late-onset disease would result from gene:gene and gene:environment interactions. We previously demonstrated that WDR36 mutations encode functional defects that affect cell growth when expressed in the homologous UTP21 gene in haploid yeast carrying a null mutation in a second gene, the co-chaperone STI1. Our aim is to investigate if STI1 directly acts as a modifier of WDR36 variation in POAG patients.

Methods: : One novel POAG-exclusive non-synonymous amino acid variant was discovered in 1/139 patients (all heterozygous for WDR36 variants) who were screened by direct sequencing of STI1 coding exons. This patient was doubly heterozygous, for STI1(K434R) and WDR36(L25P). Yeast strains expressing mutant forms of yUTP21 in a sti1 null background were transformed with plasmids expressing the wild-type or K434R variants of hSTI1, and assayed for growth rate.

Results: : A yeast strain co-expressing yUTP21(D621G) - homologous to hWDR36(D658G) - and hSTI1(K434R) exhibited slower growth than strains with only wild-type or single-mutant constructs, indicating that hSTI1(K434R) is functionally deficient and synthetically interacts with yUTP21.

Conclusions: : These results are consistent with WDR36 and STI1 being co-modifier genes affecting POAG susceptibility through polygenic modes of inheritance. Furthermore, we propose that the WDR36/UTP21-STI1 interaction has been conserved throughout evolution and participates in the regulation of ribosome assembly and/or stress responses that normally prevent glaucoma.

Keywords: genetics • gene modifiers • proteins encoded by disease genes 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×